Electrophysiological effects of the new antiarrhythmic drug 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide++ + on dog cardiac muscle

Arzneimittelforschung. 1989 Jan;39(1):56-9.

Abstract

The effects of 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide (AN-132), a new antiarrhythmic drug, on the electrical activities of dog ventricular muscles and Purkinje fibers were studied using standard microelectrode techniques. In ventricular muscles, AN-132 (10(-5)-10(-4) mol/l) decreased the overshoot potential and the maximum rate of rise of the action potential without changing the resting membrane potential, the plateau potential and the action potential duration at a driving rate of 0.5 Hz. These results indicate that AN-132 belongs to class 1 antiarrhythmic drugs. Lidocaine (10(-6)-10(-4) mol/l) failed to affect these parameters under the same conditions. In Purkinje fibers, both drugs decreased the plateau potential and shortened the action potential duration. To subclassify AN-132 among class 1 antiarrhythmic drugs, the kinetics of onset of rate-dependent effect of AN-132 (10(-4) mol/l) was compared with that of lidocaine (10(-4) mol/l), and AN-132 was found to have the slower onset kinetics than lidocaine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Anilides / pharmacology*
  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Dogs
  • Ethylenediamines / pharmacology*
  • Female
  • Heart / drug effects*
  • In Vitro Techniques
  • Lidocaine / pharmacology
  • Male
  • Membrane Potentials / drug effects
  • Purkinje Fibers / drug effects

Substances

  • 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide, diphosphoric acid
  • Anilides
  • Anti-Arrhythmia Agents
  • Ethylenediamines
  • Lidocaine